Alerts will be sent to your verified email
Verify Email
OXYGENTAPH
|
Oxygenta Pharma
|
IndoAmerican Advance
|
Aarey Drugs & Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
16.56 % | 0.31 % | 4.4 % |
|
5yr average Equity Multiplier
|
-1.71 | 1.07 | 2.28 |
|
5yr Average Asset Turnover Ratio
|
1.26 | 0.15 | 1.58 |
|
5yr Avg Net Profit Margin
|
-10.07 % | -36.65 % | 1.23 % |
|
Price to Book
|
0.0 | n/a | 1.22 |
|
P/E
|
0.0 | n/a | 52.68 |
|
5yr Avg Cash Conversion Cycle
|
-21.7 Days | 0.0 | 60.21 Days |
|
Inventory Days
|
80.38 Days | 0.0 | 21.8 Days |
|
Days Receivable
|
20.8 Days | 0.0 | 122.43 Days |
|
Days Payable
|
154.17 Days | 167.71 Days | 103.05 Days |
|
5yr Average Interest Coverage Ratio
|
-3.16 | -55.68 | 3.59 |
|
5yr Avg ROCE
|
-3.19 % | -12.15 % | 8.53 % |
|
5yr Avg Operating Profit Margin
|
-9.3 % | -72.03 % | 1.54 % |
|
5 yr average Debt to Equity
|
-1.91 | 0.0 | 0.22 |
|
5yr CAGR Net Profit
|
n/a | n/a | -9.19 % |
|
5yr Average Return on Assets
|
-6.87 % | -11.02 % | 1.94 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
55.93 % | 0.97 % | 39.06 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
43.6 % | -17.4 % | -10.97 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.04 % | 0.0 | 0.0 |
|
Oxygenta Pharma
|
IndoAmerican Advance
|
Aarey Drugs & Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|